Signs you may be underdosed Zero appetite changes after 2 or more weeks at a dose that should produce noticeable effects (typically 4mg and above)
If shedding starts at months three to six, it is almost certainly telogen effluvium and it will resolve
View image online ( Eye with uveitis Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists, commonly used to treat Type 2 diabetes and obesity, have a significantly lower risk of developing noninfectious uveitis compared with patients not taking the medication
The Yale Center for Weight Management, a collaboration between Yale New Haven Health and Yale School of Medicine, brings together obesity medicine specialists across cardiology, gastroenterology, endocrinology, and orthopaedics, along with dietitians, psychologists, and exercise physiologists
It promotes lipid mobilization from adipose tissue, enhances hepatic glucose modulation, and increases energy expenditure in ways that the GLP-1/GIP combination alone does not fully achieve
Which is more effective for weight loss, semaglutide GLP-1 or Zepbound